Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| ET Excalipoint TherapeuticsCompany profile Develops next-generation T-cell engager therapies for cancer and autoimmune diseases Develops next-generation T-cell engager therapies for cancer and autoimmune diseases | $27.7M | Seed+Seed | Biotech | China | Investors | |
| CT Crossbow Therapeutics develops antibody therapies for cancer. | $77M | Series B | Biotech | United States | Investors | |
| CS Condor SoftwareCompany profile Provides financial intelligence platform for life sciences companies to unify clinical operational and financial data Provides financial intelligence platform for life sciences companies to unify clinical operational and financial data | $24M | Series A | Biotech | United States | Investors | |
| R RiviaCompany profile Builds a data engine for clinical trial intelligence to unify fragmented data and enable AI-driven insights Builds a data engine for clinical trial intelligence to unify fragmented data and enable AI-driven insights | $15M | Series A | Biotech, Healthtech | Switzerland | Investors | |
| R Transforms carbon into essential materials using proprietary enzyme platform | $7.5M | Undisclosed | Biotech, Climate tech | United States | Investors | |
| VB Develops stroke therapeutics | $45M | Series A | Biotech | United States | Investors | |
| S SequentialCompany profile Develops non-invasive multi-omic testing platform for skin health and cosmetics using AI and microbiome analysis Develops non-invasive multi-omic testing platform for skin health and cosmetics using AI and microbiome analysis | $3.5M | Seed | Biotech, Healthtech | United States | Investors | |
| ST Surf TherapeuticsCompany profile Develops non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases Develops non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases | $6M | Seed | Biotech, Healthtech | United States | Investors | |
| B Develops liquid biopsy technology for early cancer detection | £15.8M | Series A | Biotech | United Kingdom | Investors | |
| CM Combat MedicalCompany profile Develops hyperthermic intravesical chemotherapy treatment for BCG unresponsive bladder cancer Develops hyperthermic intravesical chemotherapy treatment for BCG unresponsive bladder cancer | £2.6M | Series A | Biotech, Healthtech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →